(“Summit Therapeutics” or the “Company”)
Notification of Transactions of Persons Discharging Managerial Responsibilities
Number of Ordinary Shares Sold | Sale Price per Ordinary Share* | Number of Warrants Transferred | |
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
1,753,780 | 263,067 | ||
10,522,705 | 1,578,405 | ||
10,522,705 | 1,578,405 | ||
Total | 33,321,870 | 4,998,279 |
* The sale price per ordinary share has been converted from US Dollars at an exchange rate of
Following the completion of these dealings,
Shareholding | % of Issued Share Capital | Warrants | ||
Non-Executive Director | 211,123,385 | 62.85% | 19,925,276 |
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person responsible for arranging for the release of this announcement on behalf of the Company is
About
For more information, please contact:
Summit | ||
Tel: | 44 (0)1235 443 951 | |
+1 617 225 4455 | ||
Tel: | +44 (0)20 7213 0880 | |
N+1 Singer (Joint Broker) | Tel: | +44 (0)20 7496 3000 |
Tel: | +44 (0)20 7332 2500 | |
Tel: | +1 781 684 6552 | |
summit@mslgroup.com | ||
Tel: | +44 (0)20 3709 5700 | |
summit@consilium-comms.com |
The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.
1 | Details of the persons discharging managerial responsibilities/person closely associated | ||||
a) | (i) | ||||
2 | Reason for the notification | ||||
a) | Position / status | (i) Non-Executive Director | |||
b) | Initial notification / Amendment | Initial notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | |||||
b) | LEI | 213800NRW8AOMYMTBD89 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of 1 penny each | |||
Identification code | GB00BN40HZ01 | ||||
b) | Nature of the transactions | Sale of ordinary shares of one penny nominal value | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
(i) 22.1p (exercise price) | (i) 33,321,870 | ||||
d) | Aggregated information - Aggregated volume - Price | 33,321,870 ordinary shares | |||
e) | Date of the transactions | ||||
f) | Place of the transactions | Outside a trading venue |
1 | Details of the persons discharging managerial responsibilities/person closely associated | ||||
a) | (ii) | ||||
2 | Reason for the notification | ||||
a) | Position / status | (ii) Non-Executive Director | |||
b) | Initial notification / Amendment | Initial notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | |||||
b) | LEI | 213800NRW8AOMYMTBD89 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument | Ordinary shares of 1 penny each | |||
Identification code | GB00BN40HZ01 | ||||
b) | Nature of the transactions | Transfer of warrants to subscribe for ordinary shares of one penny nominal value | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
(i) n/a | (ii) 4,998,279 | ||||
d) | Aggregated information - Aggregated volume - Price | 4,998,279 warrants to subscribe for ordinary shares n/a | |||
e) | Date of the transactions | ||||
f) | Place of the transactions | Outside a trading venue |
-END-
© OMX, source